Carter's Vs. Neurogene Industry Stock Comparison

Sell

14

CRI
Carter's

Last Price:

53.99

Seasonality Move:

3.24%

Buy

75

NGNE
Neurogene

Last Price:

64.32

Seasonality Move:

58.98%

Sell

14

Carter's (CRI) is a Sell

Is Carter's a Buy, Sell or Hold?

The current Carter's [CRI] share price is $54.00. The Score for CRI is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
CRI is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk could be especially high.

Buy

75

Neurogene (NGNE) is a Buy

Is Neurogene a Buy, Sell or Hold?

The current Neurogene [NGNE] share price is $66.00. The Score for NGNE is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
NGNE is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

CRI Stock Price Chart

What is Carter's's stock price today?

The Carter's share price today is $54.00
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRI is experiencing slight buying pressure.

NGNE Stock Price Chart

What is Neurogene's stock price today?

The Neurogene share price today is $66.00
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NGNE is experiencing buying pressure, which is a positive indicator for future bullish movement.

CRI Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-3.05	Sell
Relative Strength Index (14 RSI):	25.7	Sell
Chaikin Money Flow:	463250	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(56.66 - 66.22)	Sell
Bollinger Bands (100):	(59.62 - 67.38)	Sell

NGNE Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	2.06	Buy
Relative Strength Index (14 RSI):	75.97	Buy
Chaikin Money Flow:	176225	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	( - )	Buy
Bollinger Bands (100):	( - )	Buy

CRI Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	55.15	Sell
20-day SMA:	60.76	Sell
50-day SMA:	64.68	Sell
200-day SMA:	69.53	Sell
8-day EMA:	56.06	Sell
20-day EMA:	59.61	Sell
50-day EMA:	62.6	Sell
200-day EMA:	66.99	Sell

NGNE Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	48.43	Buy
20-day SMA:	49.56	Buy
50-day SMA:	43.32	Buy
200-day SMA:	37.93	Buy
8-day EMA:	50.65	Buy
20-day EMA:	48.54	Buy
50-day EMA:	44.96	Buy
200-day EMA:	36.96	Buy

Carter's Earnings Growth & CRI Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.74 per share, and a decrease next year of $0.30 per share.

Neurogene Earnings Growth & NGNE Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $1.11 per share.

Carter's Technical Analysis

	Oct 23	Oct 24	Oct 25	Oct 28	Oct 29	Oct 30	Oct 31	Nov 1	Nov 4	Nov 5
	Oct								Nov
	23	24	25	28	29	30	31	01	04	05
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Neurogene Technical Analysis

	Oct 23	Oct 24	Oct 25	Oct 28	Oct 29	Oct 30	Oct 31	Nov 1	Nov 4	Nov 5
	Oct								Nov
	23	24	25	28	29	30	31	01	04	05
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):